Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-03
DOI
10.1186/s12935-020-01458-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
- (2019) Marlena Beyreis et al. Cancers
- Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
- (2019) Lambert C. J. Dorssers et al. BRITISH JOURNAL OF CANCER
- ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
- (2018) Z. Kozovska et al. BMC CANCER
- BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC
- (2018) Lauren MacDonagh et al. CANCER LETTERS
- ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells
- (2018) Erika Durinikova et al. BMC CANCER
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells
- (2016) Johannes Klose et al. BMC CANCER
- Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors
- (2016) Thibault de la Motte Rouge et al. GYNECOLOGIC ONCOLOGY
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
- (2016) Dongsheng Huang et al. Scientific Reports
- Sambamba: fast processing of NGS alignment formats
- (2015) Artem Tarasov et al. BIOINFORMATICS
- Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour
- (2015) Toyomi Satoh et al. EUROPEAN JOURNAL OF CANCER
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells
- (2015) CHEN ZHANG et al. ONCOLOGY REPORTS
- Lung cancer tumorigenicity and drug resistance are maintained through ALDHhi CD44hi tumor initiating cells
- (2015) Jing Liu et al. Oncotarget
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
- (2014) Lourdes Cortes-Dericks et al. BMC CANCER
- Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors
- (2014) Jubilee Brown et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Comprehensive analysis of DNA methylation data with RnBeads
- (2014) Yassen Assenov et al. NATURE METHODS
- Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
- (2014) Ileabett M. Echevarría-Vargas et al. PLoS One
- Prediction of Cancer Incidence and Mortality in Korea, 2014
- (2014) Kyu-Won Jung et al. Cancer Research and Treatment
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Molecular Characteristics of Malignant Ovarian Germ Cell Tumors and Comparison With Testicular Counterparts: Implications for Pathogenesis
- (2013) Sigrid Marie Kraggerud et al. ENDOCRINE REVIEWS
- Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy
- (2013) SHIMPEI NISHIKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
- (2013) H. Hou et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of the cancer stem cell related determinants of radioresistance
- (2013) Claudia Peitzsch et al. RADIOTHERAPY AND ONCOLOGY
- Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species
- (2013) Jin Zhou et al. TOXICOLOGY LETTERS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
- (2012) Yi Zhang et al. CANCER LETTERS
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Quality control and preprocessing of metagenomic datasets
- (2011) R. Schmieder et al. BIOINFORMATICS
- Salinomycin can effectively kill ALDHhigh stem-like cells on gastric cancer
- (2011) Qiao Ming Zhi et al. BIOMEDICINE & PHARMACOTHERAPY
- Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance
- (2011) J N Jeyapalan et al. BRITISH JOURNAL OF CANCER
- Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
- (2011) Anna Golebiewska et al. Cell Stem Cell
- Establishment of Cisplatin-Resistant Ovarian Yolk Sac Tumor Cells and Investigation of the Mechanism of Cisplatin Resistance Using This Cell Line
- (2011) Kiyosumi Shibata et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors
- (2011) Giorgia Mangili et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Identification and characterization of cancer stem cells in ovarian yolk sac tumors
- (2010) Shiro Suzuki et al. CANCER SCIENCE
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Prognostic factors in women treated for ovarian yolk sac tumour: A retrospective analysis of 84 cases
- (2010) Thibault de La Motte Rouge et al. EUROPEAN JOURNAL OF CANCER
- Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance
- (2010) Hendrik Wermann et al. JOURNAL OF PATHOLOGY
- Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors
- (2009) Fenghua Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
- (2009) R. Garzon et al. BLOOD
- The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines
- (2009) Jackie Perry et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
- (2008) T. de La Motte Rouge et al. ANNALS OF ONCOLOGY
- Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development
- (2008) Samir Kumar Patra et al. CANCER AND METASTASIS REVIEWS
- Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice
- (2008) Lucia Kucerova et al. JOURNAL OF GENE MEDICINE
- Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas
- (2008) Bernard Têtu et al. MODERN PATHOLOGY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Establishment and Characterization of an Ovarian Yolk Sac Tumor Cell Line Reveals Possible Involvement of Nkx2.5 in Tumor Development
- (2008) Kiyosumi Shibata et al. ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search